| Jul 31 |
Amarin Corporation plc (AMRN) Q2 2024 Earnings Call Transcript
|
| Jul 31 |
Amarin Corporation plc 2024 Q2 - Results - Earnings Call Presentation
|
| Jul 31 |
Amarin Non-GAAP EPS of $0.01 beats by $0.07, revenue of $67.49M beats by $16.47M
|
| Jul 31 |
Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update
|
| Jul 30 |
Amarin Q2 2024 Earnings Preview
|
| Jul 29 |
3 Breakthrough Stocks Under $10 Set for Massive Upside
|
| Jul 23 |
Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
|
| Jul 22 |
Amarin Corporation plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price
|
| Jul 17 |
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal
|
| Jul 17 |
Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024
|
